Showing results (111-120 of 305) with videos related to
Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cellsPaolo Corradini, Anna Dodero, Francesco Zallio, et al.Health and Quality of Life Outcomes|June 20, 2018
A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocolFabio Efficace, Mario Boccadoro, Antonio Palumbo, et al.Cancer|August 28, 2003
Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3Alessandra Cuttica, Francesco Zallio, Marco Ladetto, et al.Oncoimmunology|October 10, 2015
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myelomaBarbara Castella, Myriam Foglietta, Patrizia Sciancalepore, et al.Blood|May 10, 2003
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaPaolo Corradini, Michele Cavo, Henk Lokhorst, et al.Leukemia & Lymphoma|January 7, 2016
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)Benedetto Bruno, Holger W Auner, Gösta Gahrton, et al.British Journal of Haematology|May 25, 2002
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small- and large-scale Miltenyi cell sorting systemClaudia Voena, Giovanni Locatelli, Claudia Castellino, et al.Journal of Cellular and Molecular Medicine|October 13, 2009
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathwayMarta Coscia, Elena Quaglino, Manuela Iezzi, et al.Leukemia & Lymphoma|February 17, 2012
Phase II study of melphalan, thalidomide and prednisone combined with oral panobinostat in patients with relapsed/refractory multiple myelomaMassimo Offidani, Claudia Polloni, Federica Cavallo, et al.Experimental Hematology|September 10, 2003
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma cloneMarco Ladetto, Barbara Mantoan, Irene Ricca, et al.Pageof 31